In light of the rapidly changing coronavirus (COVID-19) situation, Troutman Sanders and Pepper Hamilton have postponed the effective date of their previously announced merger until July 1, 2020. The new firm – Troutman Pepper – will feature 1,100+ attorneys across 23 U.S. offices. Read more.
Barry H. Boise, a partner and vice chair of the firm's Health Sciences Department, defends and counsels pharmaceutical, medical device and life sciences companies. He is the leader of the firm's State Attorney General Practice, and serves on the firm’s Finance and Alternative Fee Committees. He is a Fellow of the American Bar Foundation.
Mr. Boise's primary emphasis is the counseling and defense of pharmaceutical and medical device companies from early stage through marketed products. He has substantial experience litigating multidistrict litigation and coordinated state court litigation. Mr. Boise represents life science and health care companies in attorney general investigation and litigation, and in other civil and criminal actions involving health care fraud and abuse.
His practice includes counseling regarding regulatory issues governing clinical trials and compliance in promotional and payor activities. He also advises clients regarding regulatory, competitor, compliance and litigation risks presented by the launch of new products and emerging technologies, including in the mobile medical applications and health IT fields.
Mr. Boise is a frequent writer and speaker on matters affecting the life sciences industry, including litigation prevention, regulatory compliance and settlement strategies. He is a member of organizations dedicated to the causes of his clients, including the Defense Research Institute and Lawyers for Civil Justice.